Skip to main content
logo
COFCO Biotechnology Co., Ltd. (SHE:000930)
China flag China · Delayed Price · Currency is CNY
5.26
-0.16 (-2.95%)
Sep 24, 2026, 3:04 PM CST

COFCO Biotechnology Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Net Income
-238.1738.3725.13-601.631,0591,130
Depreciation & Amortization
511.84511.94506.58491.84458.19449.81
Other Amortization
25.4721.2119.8317.3717.9620.79
Loss (Gain) From Sale of Assets
-60.1-60.10.15-1.16145.82203.22
Asset Writedown & Restructuring Costs
42.5544.192.2754.4513.321.48
Loss (Gain) From Sale of Investments
58.17-33.88-42.2510.334.08-41.92
Provision & Write-off of Bad Debts
1.081.6135.97-0.150.210.21
Other Operating Activities
494.83545.07546.17641.07278.15347.89
Change in Accounts Receivable
-632.39326.97-199.051,011-1,0522,418
Change in Inventory
29.38433.37-653.64679.8383.07760.34
Change in Accounts Payable
23.5674.79-42.82-287.46-329.12-414.53
Change in Other Net Operating Assets
---4.86-14.35-6.278.67
Operating Cash Flow
180.261,847155.811,958708.444,842
Operating Cash Flow Growth
-91.03%1085.69%-92.04%176.38%-85.37%-

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Capital Expenditures
-968.87-673.93-483.3-634.52-565.78-1,110
Sale of Property, Plant & Equipment
81.2261.4416.44166.32246.92270.39
Divestitures
-----160.52
Investment in Securities
-102.85--5.6-
Other Investing Activities
27.541.8290.22-104.812.6810.96
Investing Cash Flow
-860.15-467.82-376.64-572.99-300.58-667.9

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Long-Term Debt Issued
-6,9696,8777,5656,4378,253
Long-Term Debt Repaid
--7,693-6,115-7,275-6,521-11,627
Lease Payments
-30.01-30.04-31.83-33.76-28.22-23.15
Net Debt Issued (Repaid)
612.88-723.48761.5289.33-84.59-3,374
Common Dividends Paid
-91.98-83.06-93.48-1,172-554.75-277.34
Other Financing Activities
95.5518.95-156.582.9145.05-50.03
Financing Cash Flow
616.45-787.6511.45-880.04-594.28-3,702

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Foreign Exchange Rate Adjustments
-64.2121.7227.5211.0740.37-4.32
Net Cash Flow
-127.65613.75318.14516.02-146.05467.69

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Free Cash Flow
-788.611,174-327.491,323142.663,732
Free Cash Flow Growth
---827.69%-96.18%-
Free Cash Flow Margin
-4.67%6.70%-1.63%6.49%0.72%15.84%
Free Cash Flow Per Share
-0.420.63-0.180.720.082.02
Levered Free Cash Flow
-979.942,437-425.381,267192.13,071
Unlevered Free Cash Flow
-932.62,490-359.841,337246.553,170
Free Cash Flow After Leases
-818.621,143-359.321,290114.443,709

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash Income Tax Paid
244.75266.94291.39214.77227.63603.27
Change in Working Capital
-655.42779.07-938.031,346-1,2682,711